Clinical Trials on Mitochondrial DNA

Total 23394 results

The University of Hong Kong

Completed

ID HBV Vaccination With Imiquimod in OBI

Hepatitis B

Hong Kong
Maastricht University Medical Center
CyTuVax

Completed

Hepatitis B Vaccine for Non-responders

Hepatitis B

Belgium, Netherlands
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

This Study Aims to Determine the Long-term Persistence of Antibodies Against Hepatitis B and to Evaluate the Immunogenicity and Safety of Hepatitis B Vaccine in Adolescents Vaccinated in Infancy With Infanrix™ Hexa

Hepatitis B

Germany
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years

Hepatitis B | Hepatitis A

Belgium, Czech Republic
Merck Sharp & Dohme LLC

Completed

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

Hepatitis B
GlaxoSmithKline

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Hepatitis B

Spain, Czech Republic, Malaysia
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ Mothers

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Long Term Follow-Up Study 16-20 Years After Hepatitis B Vaccination in Newborns of Mothers Who Were Seropositive for Hepatitis B Envelope Antigen (HBeAg) & Hepatitis B Surface Antigen (HBsAg)

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years

Hepatitis B
Georgetown University
Cangene Corporation

Completed

Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients

Hepatitis B

United States
Western Galilee Hospital-Nahariya

Withdrawn

Prevalence of Hepatitis B Infection in the Galilee Region, Israel

Hepatitis B
GlaxoSmithKline

Completed

Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians (PRALINE)

Hepatitis B

France
University of Aarhus
Aarhus University Hospital; Monash Medical Centre

Unknown

Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders

Hepatitis B

Denmark
Far Eastern Memorial Hospital

Unknown

Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults

Hepatitis B

Taiwan
IVI Madrid

Recruiting

Impact of Telomere Biology and Sperm DNA Fragmentation on Embryonic Development

Sperm | Sperm DNA Fragmentation | Male Fertility | Telomeres

Spain
Neurophth Therapeutics Inc

Active, not recruiting

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

Leber Hereditary Optic Neuropathy (LHON)

United States
Santhera Pharmaceuticals

Completed

Study to Assess the Efficacy and Safety of Raxone in LHON Patients (LEROS)

Leber's Hereditary Optic Neuropathy (LHON)

United States, United Kingdom, Spain, Poland, Austria, Belgium, Bulgaria, Germany, Italy, Portugal
Santhera Pharmaceuticals

Completed

Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)

Leber's Hereditary Optic Neuropathy (LHON)

Belgium, Netherlands, France, Germany, Norway, United Kingdom, Italy
Mahidol University

Completed

A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)

Optic Atrophy, Hereditary, Leber

Thailand
Institut Pasteur
Institut National de la Santé Et de la Recherche Médicale, France; Gilead Sciences and other collaborators

Completed

Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule (NEOVAC2BK)

Hepatitis B

Burkina Faso
Oslo University Hospital
The Research Council of Norway; University of Agder; Addis Ababa University; St... and other collaborators

Active, not recruiting

Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa

Hepatitis B

Ethiopia
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant

Hepatitis B

United States
Sinovac Biotech Co., Ltd

Completed

Clinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg)

Hepatitis B

China
Sinovac Biotech Co., Ltd

Completed

Comparison of Immunization Schedules of Inactivated Hepatitis A Vaccine and Combined Hepatitis A and Hepatitis B Vaccine

Hepatitis B | Hepatitis A

China
University of Oxford

Completed

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Hepatitis B

United Kingdom
GlaxoSmithKline

Completed

Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

Hepatitis B | Hepatitis A

Germany, Belgium, Czechia
Peking University
Shenzhen Kangtai Biological Products Co., LTD; Guangxi Center for Disease Control... and other collaborators

Completed

A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults

Hepatitis B

China
Huashan Hospital

Completed

Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission

Hepatitis B

China
University of British Columbia
Canadian Institutes of Health Research (CIHR); Canadian Immunization Research...

Completed

Hepatitis B Booster Study in Adolescence

Hepatitis B

Canada
Corporacion Parc Tauli
Hospital Mutua de Terrassa; Consorci Sanitari de Terrassa

Completed

Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study

Hepatitis B

Spain
GlaxoSmithKline

Completed

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine

Hepatitis B

Australia, Belgium
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

Hepatitis B

Slovakia
GlaxoSmithKline

Completed

Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™

Hepatitis B | Hepatitis A

Belgium, Czechia
GlaxoSmithKline

Completed

Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in Adults

Hepatitis B | Hepatitis A

Germany, Belgium
GlaxoSmithKline

Completed

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Hepatitis B

Germany
GlaxoSmithKline

Completed

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Hepatitis B

Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 Genotype

Hepatitis B
GlaxoSmithKline

Completed

Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine

Hepatitis B | Hepatitis A

Australia
Jiangsu Province Centers for Disease Control and...
Beijing Tiantan Biological Products Co., Ltd.

Completed

Study of Evaluating Safety and Immunogenicity of 10µg/0.5ml Hepatitis B Vaccine

Hepatitis B

China
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Hepatitis B Seroepidemiology Among Young Adults

Hepatitis B

Taiwan
Public Health Service of Amsterdam
UMC Utrecht

Unknown

Cohort of Hepatitis B Research of Amsterdam (COBRA)

Hepatitis B

Netherlands
Kirby Institute

Completed

Hepatitis B Acceptability and Vaccination Incentive Trial (HAVIT)

Hepatitis B

Australia
Baylor College of Medicine
Centers for Disease Control and Prevention

Unknown

Adolescents' Response to Hepatitis B Vaccine Booster Dose (REACH)

Hepatitis B

United States
Yale University
National Institute on Drug Abuse (NIDA); Case Western Reserve University; DePaul... and other collaborators

Completed

Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination Schedules (HVS)

Hepatitis B

United States
University of British Columbia

Completed

Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator

Hepatitis B

Canada

3

Subscribe